Six decades of autonomic testing map how a healthy heart's rate is controlled
A Brazilian lab's narrative review of ~60 years of testing in healthy men shows how vagal and sympathetic branches split control of heart rate.
Résumé
This narrative review from a Brazilian cardiology lab pulls together nearly 60 years of work on how the autonomic nervous system controls heart rate in healthy young men. Using drug blockade of the vagal (atropine) and sympathetic (propranolol) branches, the team found a consistent two-phase pattern: vagal withdrawal drives the first seconds of tilt, handgrip and cycling, then sympathetic activation takes over. Most tests, including baroreflex testing, Valsalva, tilt, respiratory sinus arrhythmia and heart rate variability, looked usable as reference standards. Face immersion was not reproducible. This is a physiology reference, not an intervention study, and it involved small groups of men aged 19 to 43. It sets baselines for spotting autonomic dysfunction in disease, which part two covers.
Résumé détaillé
Autonomic regulation of heart rate is a core part of cardiovascular aging. Declining vagal tone and baroreflex sensitivity are linked to worse outcomes, so a validated set of reference tests matters for anyone trying to measure autonomic health rather than guess at it. This review, part one of two, collects roughly 55 to 60 years of standardized testing from one Brazilian laboratory.
The studies enrolled small groups of healthy men (8 to 23 per study, mean age 27 to 31, range 19 to 43), unmedicated and cleared by clinical evaluation. Heart rate and blood pressure were recorded at rest and after intravenous atropine (0.04 mg/kg, vagal blockade), propranolol (0.2 mg/kg, beta-sympathetic blockade), or both, which reveals the sinus node's intrinsic rate. Tests included baroreflex sensitivity (phenylephrine and amyl nitrite pressure changes), Valsalva ratio, 70° passive tilt, isometric handgrip, cycle ergometry at 25 to 100 W, respiratory sinus arrhythmia at 6 breaths/min, spectral heart rate variability from 24-hour Holter, and 123I-MIBG imaging of cardiac sympathetic innervation.
The central result was a biphasic pattern. In tilt, handgrip and cycling, the rapid rise in heart rate in the first ~10 seconds was abolished or blunted by atropine, so it reflects vagal withdrawal. Propranolol mainly reduced the later, slower rise (after ~10 seconds of handgrip, 1 to 5 minutes of tilt or cycling, especially at higher loads), reflecting sympathetic drive. A combined handgrip-plus-cycling protocol suggested the gradual heart rate climb from minute 1 to 4 of cycling was not explained by vagal withdrawal, offering a way to probe vagal dynamics without drugs.
Not every test held up. Face immersion produced variable bradycardia, water temperature had no appreciable effect, adding breath-holding did not potentiate it, and atropine failed to reduce the response in two of three retested subjects. It was the only method judged insufficiently reproducible for routine clinical use. The authors note the low-frequency heart rate variability band likely carries both sympathetic and vagal influence, so the LF/HF ratio is an imperfect index of balance.
The practical value is a physiological yardstick. Tilt testing is already useful in diabetes, syncope and suspected autonomic neuropathy, and the paper says the other methods have clinical potential. Caveats are substantial: all-male, small samples, mostly young adults, a single center, and a narrative rather than systematic review. Aging and endurance training are mentioned but the excerpt provided gives no quantitative results for them, and no lifespan or outcome data are reported.
Principales conclusions
- Heart rate rise in the first ~10 seconds of tilt, handgrip and cycling was vagal withdrawal, blocked by atropine.
- Propranolol mainly blunted the later heart rate rise (after ~10 s handgrip, 1-5 min tilt or cycling), showing sympathetic takeover.
- Handgrip during cycling still raised heart rate, so the slow climb from minutes 1-4 was not due to vagal withdrawal.
- Face immersion bradycardia was variable and not abolished by atropine in 2 of 3 retested subjects; it was not reproducible.
Méthodologie
Narrative review summarizing one laboratory's prior physiological studies in small groups of healthy, unmedicated men (8 to 23 per study, ages 19 to 43). Tests were done at baseline and under atropine, propranolol, or dual pharmacologic blockade, using invasive arterial pressure monitoring in some protocols. Endpoints were heart rate and blood pressure responses (a physiological function measure), with no clinical outcomes or lifespan data.
Limites de l'étude
All participants were young to middle-aged men in small samples from a single laboratory, so findings may not generalize to women or older adults. Some protocols were tiny (for example, 3 subjects retested after atropine), and this is a narrative review without systematic methods. The provided text lacks quantitative aging and training results and the final table, and LF/HF interpretation remains debated.
Ce résumé vous a plu ?
Recevez les dernières recherches sur la longévité dans votre boîte de réception chaque semaine.
Saisissez votre e-mail pour vous abonner :
